These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 14684596)

  • 1. Mesalazine is safe for the treatment of IBD.
    D'Haens G; van Bodegraven AA
    Gut; 2004 Jan; 53(1):155. PubMed ID: 14684596
    [No Abstract]   [Full Text] [Related]  

  • 2. How safe are the safest IBD drugs?
    Lewis JD
    Gastroenterology; 2003 Jun; 124(7):1986-7; discussion 1987-8. PubMed ID: 12806636
    [No Abstract]   [Full Text] [Related]  

  • 3. Mesalamine intolerance mimics symptoms of active inflammatory bowel disease.
    Iofel E; Chawla A; Daum F; Markowitz J
    J Pediatr Gastroenterol Nutr; 2002 Jan; 34(1):73-6. PubMed ID: 11753169
    [No Abstract]   [Full Text] [Related]  

  • 4. [Adverse effects of sulfasalazine: discussion of mechanism and role of sulfonamide structure].
    Atheymen R; Affes H; Ksouda K; Mnif L; Sahnoun Z; Tahri N; Zeghal KM; Hammami S
    Therapie; 2013; 68(6):369-73. PubMed ID: 24356188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines.
    Ransford RA; Langman MJ
    Gut; 2002 Oct; 51(4):536-9. PubMed ID: 12235076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypereosinophilia due to mesalazine treatment.
    Usta Y; Ozen H; Gurakan F; Uslu N; Saltik-Temizel IN; Demir H; Yuce A
    J Clin Gastroenterol; 2009 Apr; 43(4):382. PubMed ID: 19309777
    [No Abstract]   [Full Text] [Related]  

  • 7. Nephrotic syndrome associated with inflammatory bowel disease treated by mesalazine.
    Skhiri H; Knebelmann B; Martin-Lefevre L; Grunfeld JP
    Nephron; 1998; 79(2):236. PubMed ID: 9647514
    [No Abstract]   [Full Text] [Related]  

  • 8. Methaemoglobinaemia and renal failure following mesalazine for treatment of inflammatory bowel disease.
    Druez A; Rahier JF; Hébuterne X
    J Crohns Colitis; 2014 Aug; 8(8):900-1. PubMed ID: 24486176
    [No Abstract]   [Full Text] [Related]  

  • 9. Mesalazine and Nephrolithiasis: Leave No Stone Unturned.
    Simsek M; de Boer NKH
    Am J Gastroenterol; 2019 Aug; 114(8):1359-1360. PubMed ID: 31261253
    [No Abstract]   [Full Text] [Related]  

  • 10. Pyelonephritis caused by mesalazine.
    Russo GE; Bauco B; Bosco M; Bonello M; Bisciglia MF; De Paola A; Villatico Campbell S; Fava D; Vitaliano E
    Nephron; 2000 Oct; 86(2):228-9. PubMed ID: 11015014
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety of high doses of mesalazine during pregnancy.
    Marteau P; Seksik P; Couve S; Jian R
    Am J Gastroenterol; 2005 Aug; 100(8):1897-8. PubMed ID: 16086733
    [No Abstract]   [Full Text] [Related]  

  • 12. Mesalazine-associated acute tubulointerstitial nephritis in a patient with spondylarthropathy.
    Sari I; Birlik M; Cavdar C; Sarioglu S; Akpinar H; Onen F; Akkoc N
    N Z Med J; 2005 Sep; 118(1222):U1662. PubMed ID: 16222356
    [No Abstract]   [Full Text] [Related]  

  • 13. Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines.
    Logan RF; van Staa TP
    Gut; 2003 Oct; 52(10):1530; author reply 1530-1. PubMed ID: 12970150
    [No Abstract]   [Full Text] [Related]  

  • 14. Mesalamine: safe at first look.
    Saubermann LJ; Wolf JL
    Inflamm Bowel Dis; 1999 May; 5(2):148-9. PubMed ID: 10338388
    [No Abstract]   [Full Text] [Related]  

  • 15. The risk of sulfasalazine- and mesalazine-associated blood disorders.
    Jick H; Myers MW; Dean AD
    Pharmacotherapy; 1995; 15(2):176-81. PubMed ID: 7624265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy outcome in women with inflammatory bowel disease following exposure to 5-aminosalicylic acid drugs: a meta-analysis.
    Rahimi R; Nikfar S; Rezaie A; Abdollahi M
    Reprod Toxicol; 2008 Feb; 25(2):271-5. PubMed ID: 18242053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effect of mesalazine and sulfasalazine on laboratory parameters: a retrospective observational study.
    Masuda H; Takahashi Y; Nishida Y; Asai S
    Eur J Clin Pharmacol; 2012 Nov; 68(11):1549-55. PubMed ID: 22546896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesalazine. Now authorised for children, but no suitable form.
    Prescrire Int; 2011 Sep; 20(119):208. PubMed ID: 21954515
    [No Abstract]   [Full Text] [Related]  

  • 19. 5-Aminosalicylic acid (5-ASA) and chronic tubulointerstitial nephritis in patients with chronic inflammatory bowel disease: is there a link?
    De Broe ME; Stolear JC; Nouwen EJ; Elseviers MM
    Nephrol Dial Transplant; 1997 Sep; 12(9):1839-41. PubMed ID: 9306332
    [No Abstract]   [Full Text] [Related]  

  • 20. Reproductive issues in inflammatory bowel disease.
    Saha S; Esposti SD
    Med Health R I; 2009 Apr; 92(4):148-51. PubMed ID: 19452759
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.